MDT perspectives on the importance of patient engagement in PARPi use - Video 3

touchMDT for touchONCOLOGY

Listen to experts Dr Alicia Morgans, Dr Grace Cullen, and patient advocate, Mr Tony Collier, discuss the importance and practicalities of engaging patients in their care and hear insights from the perspective of a patient advocate in relation to the use of PARP inhibitors.

The multidisciplinary team and patient advocate:

Medical oncologist – Dr Alicia Morgans
Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Nurse practitioner – Dr Grace Cullen

John D. Dingell VA Medical Center, Detroit, Michigan, USA

Patient Advocate – Mr Tony Collier
Tackle Prostate Cancer, London, UK

This touchPODCAST is for HCPs outside of the UK only.

This activity is supported by an independent medical education funding request from AstraZeneca.

This activity is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider.

For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitors-in-mcrpc/